Exenatide Shows Sustained Improvements in Glycemic Control

COPENHAGEN — Exenatide provides sustained improvements in glycemic control and progressive reductions in body weight for up to 2 years in patients with type 2 diabetes, Dr. Robert R. Henry and his associates reported in a poster at the annual meeting of the European Association for the Study of Diabetes.